A Phase II Efficacy Study Of Intravenous Edotecarin In Patients With Advanced Gastric Cancer That Has Progressed Or Recurred After Prior Fluoropyrimidine-Based Chemotherapy (Pfizer)

Project Details

Short titleA Phase II Efficacy Study Of Intravenous Edotecarin In Patients With Advanced Gastric Cancer That Has Progressed Or Recurred After Prior Fluoropyrimidine-Based Chemotherapy (Pfizer)
StatusFinished
Effective start/end date1/04/0431/12/07

Funding

  • Queen Elizabeth Hospital Birmingham